NEU1 and idiopathic pulmonary fibrosis: Most recent study presents NEU1-selective inhibitor, C9-BA-DANA, mimetic of sialic acid, that dose-dependently inhibited bleomycin-induced lung fibrosis in mouse models (131), presenting its therapeutic potential for IPF patients.